Treatment with danaparoid during pregnancy for a woman with a cutaneous allergy to low-weight molecular heparin.

被引：0

作者：

de Saint-Blanquat, L ^{[1
]}

Simon, L ^{[1
]}

Toubas, MF ^{[1
]}

Hamza, J ^{[1
]}

机构：

[1] Hop St Vincent de Paul, Serv Anesthesie Reanimat Chirurg, F-75014 Paris, France

来源：

ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION | 2000年 / 19卷 / 10期

关键词：

cutaneous allergy; danaparoid sodium; pregnancy; LMWH;

D O I：

暂无

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

The authors describe a case of heparin-induced skin reaction due to two preparations of low molecular weight heparin in a pregnant woman. The main characteristics of heparin-related cutaneous allergy are reported. The use of an heparinoid, usually indicated for patients with heparin-induced thrombocytopenia, appeared to be efficient and safe for the mother and her fetus. An epidural analgesia was performed for labor analgesia, 24 hours after the last injection of danaparid of sodium. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

引用

页码：751 / 754

页数：4

共 50 条

[21] Use of the low-molecular-weight heparin nadroparin during pregnancy. A review
Makatsaria, AD
Bitsadze, VO
Dolgushina, NV
CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (01) : 4 - 12
[22] Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?
van Lennep, J. E. Roeters
Meijer, E.
Klumper, F. J. C. M.
Middeldorp, J. M.
Bloemenkamp, K. W. M.
Middeldorp, S.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (03) : 473 - 480
[23] The use of unfractionated heparin and low molecular weight heparins in pregnancy
Casele, Holly L.
CLINICAL OBSTETRICS AND GYNECOLOGY, 2006, 49 (04) : 895 - 905
[24] Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications
Kupferminc, Michael J.
Rimon, Eli
Many, Ariel
Sharon, Maslovitz
Lessing, Joseph B.
Gamzu, Ronni
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2011, 24 (08) : 1042 - 1045
[25] Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?
Leyh, RG
Fischer, S
Ruhparwar, A
Haverich, A
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (03) : 577 - 579
[26] A critical analysis of low molecular weight heparin use during pregnancy in a tertiary referral centre
Kutuk, M. S.
Terzioglu, A.
Ozgun, M. T.
Uludag, S.
Dolanbay, M.
Tas, M.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 34 (02) : 131 - 134
[27] THROMBOCYTOPENIA, ANTITHROMBIN DEFICIENCY AND EXTENSIVE THROMBOEMBOLISM IN PREGNANCY - TREATMENT WITH LOW-MOLECULAR-WEIGHT HEPARIN
MACKLON, NS
GREER, IA
REID, AW
WALKER, ID
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (07) : 672 - 675
[28] Low molecular weight heparin use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis
Sirico, Angelo
Saccone, Gabriele
Maruotti, Giuseppe Maria
Grandone, Elvira
Sarno, Laura
Berghella, Vincenzo
Zullo, Fulvio
Martinelli, Pasquale
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (11) : 1893 - 1900
[29] Meta-Analysis of the Efficacy of Low Molecular Weight Heparin and Aspirin in the Treatment of Thrombosis During Pregnancy and Effects on Coagulation Function
Yin, Meng
Qin, Xiaosong
DISCOVERY MEDICINE, 2023, 35 (175) : 104 - 115
[30] The manncrement of thrombosis in pregnancy: Role of low-molecular-weight heparin
Kher, Andre
Bauersachs, Rupert
Nielsen, Jorn Dalsgaard
THROMBOSIS AND HAEMOSTASIS, 2007, 97 (04) : 505 - 513

← 1 2 3 4 5 →